Ocular manifestations of rheumatologic diseases
Main Article Content
Abstract
Objective: Analyze about the various ocular alterations related to rheumatic diseases, as well as to discuss their etiology, pathophysiology, clinical manifestations, risk factors, diagnostic and therapeutic approach. Bibliographic review: Rheumatic diseases, called autoimmune diseases, occur when the body's immune system reacts against healthy cells, causing inflammation that affects mainly the locomotor system. Diagnosis is based on history and physical examination, since laboratory tests have low sensitivity and specificity. Therefore, the identification is difficult and many times it can be confused with other pathologies. Moreover, patients with autoimmune diseases can develop secondary diseases, such as ocular complications like uveitis, dry keratoconjunctivitis, episcleritis, scleritis, and others. Thus, the manifestations vary according to the type of rheumatism expressed, as well as the treatment to be applied. Final consideration: Rheumatic disorders cause ocular manifestations that should be followed by professionals in the area, in order to prevent and/or diagnose them.
Article Details
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
References
2. DIAS CZ, et al. Perfil dos usuários com doenças reumáticas e fatores associados à qualidade de vida no sistema único de saúde, Brasil. Rev Méd Minas Gerais. 2017; 27: 1–7.
3. FOULKS GN, et al. Clinical Guidelines for management of dry eye associated with Sjögren disease. The Ocular Surface, 2015; 13: 118-132.
4. GENERALI E, et. al. Ocular Involvement in Systemic Autoimmune Diseases. Clinical Reviews In Allergy & Immunology. Springer Science and Business Media LLC. 2015; 49: 263-270.
5. GOELDNER I, et al. Artrite reumatóide: uma visão atual. Journal Brasileiro de Patologia Médica Laboratorial. 2011; 47: 495-503.
6. GOUVEIA EB, et al. Espondilite anquilosante e uveíte: revisão. Revista Brasileira de Reumatologia. 2012; 52: 749-756.
7. GUPTA N. Management of Uveitis in Spondyloarthropathy: Current Trends. The Permanente Journal. 2018; 22: 17-41.
8. KEMENY-BEKE A, SZODORAY P. Ocular manifestations of rheumatic diseases. International Ophthalmology Springer Science and Business Media LLC. 2019; 40(2): 503-510.
9. KURODA K, et.al. Late-Onset Systemic Lupus Erythematosus Associated with Autoinmune Hemolytic Anemia and Sixth Cranial Nerve Palsy. American Journal of Case Reports. 2021; 22: 1-5.
10. MENDES LE, et. al. Alterações oculares no lupus eritematoso sistêmico. Arquivos Brasileiros de Oftalmologia. GN1 Genesis Network. 1998; 61: 713-716.
11. MITULESCU TC, et. al. Advances in the treatment of uveitis in patients with spondyloarthritis - is it the time for biologic therapy? Romanian Journal Of Ophthalmology. Fundatia Universitara Sanabuna. 2018; 61: 114-122.
12. NIDA HS, et al. Periocular corticosteroid injections in uveitis: effects and complications. Ophthalmology, 2014; 121: 2275-2286.
13. PEREIRA IA. Envolvimento ocular nas doenças reumáticas. Revista Brasileira de Reumatologia. 2011; 44:160-167.
14. PETRIS CK, ALMONY A. Manifestações oftálmicas da doença reumatológica: diagnóstico e gestão. Missouri Medicine. 2012; 109: 53-58.
15. PEZZOLE ER, OSELAME GB. Fatores de risco para o lúpus eritematoso sistêmico: revisão da literatura. Revista Uniandrade. 2014; 15: 65-77.
16. ROCHA FAC, et. al. Advances in rheumatology practice in Brazil. Rheumatology International. Springer Science and Business Media LLC. 2018; 39:1125-1134.
17. SANGHA O. Epidemiology of rheumatic diseases. Rheumatology Oxford. 2000; 39: 3-12.
18. SOCIEDADE BRASILEIRA DE PEDIATRIA. 2014. In: O que é Febre Reumática?. Disponível em: https://www.sbp.com.br/imprensa/detalhe/nid/o-que-e-febre-reumatica/. Acessado em: 15 de nov. de 2021.
19. SOCIEDADE BRASILEIRA DE REUMATOLOGIA. 2011. In: Síndrome da Fibromialgia-Diagnóstico Diferencial. Disponível em: https://www.reumatologia.org.br/orientacoes-ao-paciente/sindrome-da-fibromialgia-diagnostico-diferencial/. Acessado em: 15 de nov. de 2021.
20. SONODA RT, et al. Espondilite Anquilosante, distúrbios sistêmicos e oculares. Revista Científica Multidisciplinar. 2021; 2: 717- 971.
21. SPINA GS. Doença reumática: negligenciada, mas ainda presente e mortal. Revista de Medicina. Universidade de São Paulo, Agência USP de Gestão da Informação Academica (AGUIA). 2008; 87: 128.
22. TEIXEIRA MEF. Avaliação da concordância de diagnóstico das doenças reumáticas entre os níveis primário e terciário de atenção à saúde. 2021, 1:1-33.
23. TREVISANI VFM. Manifestações oftalmológicas em reumatologia. Revista Paulista de Reumatologia, São Paulo. 2014; 1: 11-13.
24. VALE IMS. Análise da frequência de uveítes em pacientes com espondiloartrites, suas complicações e associação com parâmetros clínicos da doença. Revista Brasileira de Oftalmologia. 2018; 77: 80-4.
25. VIANA D, et al. Polimialgia Reumática, Quando suspeitar?. 2021;11: 49-5.